← SynDRA
FLINDOKALNER
SynDRA canonical compound SYN0000236 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | KCNMA1 | KCNMB1 | KCNN4 | KCNQ2 | KCNQ4 | KCNQ5 |
|---|
| Mechanism of action | potassium channel agonist |
|---|
All known targets
- KCNMA1
- KCNQ2
- KCNQ4
- KCNQ5
- KCNMB1
- KCNN4
- KCNQ3
Mechanisms of action (all sources)
- KCNMA1 OPENER
- Calcium-activated potassium channel subunit alpha-1 opener
- KCNQ5 ACTIVATOR
- Voltage-gated potassium channel subunit Kv7.5 activator
- KCNQ4 ACTIVATOR
- Voltage-gated potassium channel subunit Kv7.4 activator
- KCNQ2 ACTIVATOR
- Voltage-gated potassium channel subunit Kv7.2 activator
- Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator
- KCNQ3 ACTIVATOR
- Voltage-gated potassium channel KCNQ3/KCNQ4 activator
- potassium channel agonist
Cross-references
Synonyms
- BMS-204352
- BMS-204352-01
- Maxipost
- BMS 204352
- MaxiPost
- Flindokalner [USAN:INN]
- UNII-J57O328W4W
- (3S)-3-(5-Chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one
- J57O328W4W
- 2H-Indol-2-one, 3-(5-chloro-2-methoxyphenyl)-3-fluoro-1,3-dihydro-6-(trifluoromethyl)-, (3S)-
- Maxipost (TN)
- (s)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)indolin-2-one
- (3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1H-indol-2-one
- Bms204352
- Flindokalner (USAN/INN)
- AC1Q4JQL
- AC1L4WO7
- Bms 204352
- flindokalnerum
- RefChem:569729
- (+)-MAXIPOST
- C16H10ClF4NO2
- Flindokalner [USAN]
- FLINDOKALNER [INN]
- (S)-II
- GTPL2307
- orb1308302
- SCHEMBL4877314
- SCHEMBL29388740
- SCHEMBL30322726
- GLXC-03543
- BDBM50426567
- MFCD09475617
- AKOS024458430
- SB19641
- MS-25672
- HY-108584
- CS-0029243
- (S)-(+)-BMS 204352
Look up FLINDOKALNER in the interactive SynDRA portal →